Comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 vs 3 4 Toe Syndactyly C1834062
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Exogenous Maternal Derived Androgen and 3 4 Toe Syndactyly for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
A condition caused when a pregnant person takes hormone medications containing androgens, affecting fetal development. The fetus has XX chromosomes. Stopping the offending agent is key, with specialist care for affected infants.
3 4 Toe Syndactyly C1834062
Webbing between the third and fourth toes, a common birth variation. Often requires no treatment as toes usually function normally.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Variable
3 4 Toe Syndactyly C1834062
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
severe
3 4 Toe Syndactyly C1834062
mild
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Chronic
3 4 Toe Syndactyly C1834062
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
No
3 4 Toe Syndactyly C1834062
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
reproductive
3 4 Toe Syndactyly C1834062
musculoskeletal
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
endocrine
3 4 Toe Syndactyly C1834062
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-exogenous-maternal-derived-androgen-C5679874 and 3-4-toe-syndactyly-C1834062 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3 4 Toe Syndactyly C1834062 | Discriminating power |
|---|---|---|---|
| Genital appearance | Atypical genital development may be present after prenatal androgen exposure; findings vary and are not definitive alone. | No established genital abnormality is described. | High |
| Toe webbing | Toe webbing is not part of the supplied description. | Webbing between the third and fourth toes is the defining finding and often functions normally. | High |
| Pregnancy exposure history | History of androgen-containing medication during pregnancy is central to the proposed cause. | No medication exposure is required; it is described as a common birth variation. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 when
XX infant with atypical genitalia and documented prenatal androgen exposure
The exposure history and reproductive phenotype match the supplied concept better than a toe finding.
Moderate
Need to stop a suspected androgen source in pregnancy
Stopping the offending agent is specifically described as key, with specialist follow-up.
High
Endocrine or DSD specialist assessment is planned
The concept is categorized as endocrine and reproductive rather than a mild musculoskeletal variation.
Moderate
Choose 3 4 Toe Syndactyly C1834062 when
Isolated webbing of the third and fourth toes
This matches the described birth variation and does not imply a sex-development disorder.
High
Normal toe function and no other concerns
Treatment is often unnecessary when function is normal, based on the supplied description.
Moderate
Musculoskeletal congenital variation without androgen exposure
Body system and etiology differ from exogenous androgen-related DSD.
High
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3 4 Toe Syndactyly C1834062 | Interpretation |
|---|---|---|---|
| Karyotype | XX chromosomes are part of the concept; confirm only through clinical testing. | No characteristic karyotype result is established in the source. | An XX result supports the left label only with compatible history and examination. |
| Medication and pregnancy history | Androgen-containing hormone medication exposure is the proposed cause. | No exposure history is required. | History can support causation but does not by itself prove the diagnosis. |
| Foot examination | No specific foot finding is supplied. | Visible or palpable webbing between toes 3 and 4. | Examination distinguishes the toe finding; imaging is not established as necessary. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
- Outcome
- Course may be chronic and needs specialist follow-up; specific outcomes are not established here.
- Factors
- Timing and type of exposure, examination findings, and access to specialist care.
3 4 Toe Syndactyly C1834062
- Outcome
- Usually a mild chronic structural variation with normal toe function.
- Factors
- Degree of webbing, comfort, footwear, and any separately identified conditions.
Time frame: Left begins with prenatal exposure and is recognized after birth; right is present at birth.
Prognosis should be individualized; no mortality or prevalence figures are supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Functional limitation | Possible effects on genital development and later reproductive care needs; exact outcomes are not established here. Toes usually function normally; limitation is not expected from the source. Severity is described as severe on the left and mild on the right. |
| Need for intervention | Stopping the offending agent and specialist infant care are emphasized. Often no treatment is required. Intervention decisions require individual clinician assessment. |
| Associated anomalies | Additional anomalies are not established by the supplied data. Associated anomalies are not established; isolated webbing is the described pattern. Do not infer syndromic disease from either label alone. |
Patient education highlights
- HighDifferent conditions
Androgen-related 46,XX DSD and 3-4 toe syndactyly affect different body systems and are not interchangeable diagnoses.
- HighMedication exposure
Report pregnancy hormone or androgen medication use to clinicians; do not stop prescribed medicine without medical advice.
- MediumToe care
Isolated third-fourth toe webbing often needs no treatment if walking and shoe fit are comfortable.